IKT Operating Expenses

Inhibikase Therapeutics Inc · Operating Expenses

IKT logo

IKT Operating Expenses

Latest reported$65.81M
IKT Operating Expenses ($734.29K → $65.81M)
High-resolution chart · PNG

IKT operating expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Inhibikase Therapeutics Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
51,974,283
28,562,796
6,731,944
18,245,325
6,507,641
2,623,158
4,268,177
2,122,121
2,466,067
734,287
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.